Skip to main content
. 2018 Aug 16;10:80. doi: 10.1186/s13195-018-0407-6

Fig. 2.

Fig. 2

CSF SNAP-25 by diagnosis and amyloid pathology. The subjects included in the study were classified as Aβ+ or Aβ. CSF SNAP-25 in different combinations of clinical diagnosis and Aβ pathology. Differences between groups were tested by multiple-variable linear regression, adjusted for age and sex. *p < 0.05, **p < 0.01, ***p < 0.0001. AD Alzheimer’s disease, CN cognitively normal, pMCI progressive mild cognitive impairment, sMCI stable mild cognitive impairment, SNAP-25 synaptosomal-associated protein 25